Jay Dong, founding GM (China and APAC) and Global VP of Cell Signaling Technology, shares the company’s success in the past ten years; the economic transformation in China driving the growth of the biotech and pharma industries; the cutting-edge solutions and technologies Cell Signaling Technology is committed to providing to scientists and researchers in China; and his focus on building a sustainable and supportive ecosystem for China-based innovations to reach patients in China.
With money, talent and policy coming together to foster this positive economic development, the environment is excellent [in China] for companies in general, both multinational and domestic.
